InvestorsHub Logo
Followers 21
Posts 3566
Boards Moderated 0
Alias Born 12/18/2019

Re: Itchy palm post# 199037

Monday, 01/03/2022 4:39:25 PM

Monday, January 03, 2022 4:39:25 PM

Post# of 232926
If BP gets bad numbers they get rejected, just like Cytodyn. LL's NASH open label data is mediocre at best, not competitive with the leading NASH candidates. Doubtful the 700 mg can double the fat reduction and it still would not be competitive with the leading candidates. Cytodyn didn't even report the fibrosis reduction (a secondary endpoint) which is never a good sign.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News